Archer Daniels Midland Company - ADM STOCK NEWS

ADM has announced a strategic partnership with Farmers Business Network (FBN), following an equity investment in FBN’s latest funding round. This collaboration aims to enhance farmer profitability and promote sustainable agriculture. Key initiatives include developing low-carbon grain markets, improving digital transaction systems via FBN’s Gradable platform, and facilitating easier access to ADM products for FBN’s 30,000 farmer members. This partnership leverages ADM's supply chain expertise alongside FBN's technology-driven farming solutions.

ADM has partnered with Asia Sustainable Foods Platform, a Temasek-owned company, to establish a 50-50 joint venture aimed at enhancing technology development and precision fermentation in the Asia-Pacific region. This venture will support businesses in creating alternative protein products through food-grade fermentation and consulting services. With ADM's expertise in microbial solutions, the initiative aims to meet the rising demand for sustainable food alternatives, particularly in Singapore. The collaboration is also backed by the Singapore Economic Development Board to strengthen the local agri-food ecosystem.

ADM’s Board of Directors has declared a cash dividend of 37 cents per share, payable on December 8, 2021, to shareholders of record on November 17, 2021. This marks the 360th consecutive quarterly payment, showcasing a remarkable record of 90 years of uninterrupted dividends. As of September 30, 2021, ADM had 559,439,770 shares of common stock outstanding.

With a strong commitment to sustainability and nutrition, ADM continues to lead in the agricultural sector, providing innovative solutions worldwide.

ADM expands its health and wellness portfolio by acquiring Deerland Probiotics & Enzymes. This strategic investment aims to tap into the $775 billion global demand for health products. Deerland, a leader in probiotic and enzyme technologies, complements ADM's offerings with its extensive branded product lines. The acquisition is expected to increase ADM's Health & Wellness revenue to over $500 million annually. Subject to regulatory approval, the deal will transfer approximately 320 employees to ADM.

ADM reported Q3 2021 net earnings of $526 million and adjusted net earnings of $548 million, with segment operating profit at $1 billion. Adjusted EPS rose 9% to $0.97, despite a higher effective tax rate of 18%. The company experienced consistent profit growth for eight quarters driven by strong demand and operational execution. Strategic initiatives include a 75% stake in PetDine and partnerships for sustainable solutions. Corporate costs increased, but overall performance remains strong.

ADM and Gevo, Inc. have signed a memorandum of understanding (MoU) to produce sustainable aviation fuel (SAF) from ethanol and isobutanol. This collaboration aims to transition ADM's dry mills in Columbus, Cedar Rapids, and Decatur for the production of approximately 500 million gallons of SAF from 900 million gallons of ethanol. The initiative supports growing demand for low carbon fuels, with production expected to start in the 2025-2026 timeframe. The U.S. aims to produce 4 billion gallons of SAF by 2030, increasing to over 45 billion by 2050.

ADM announces a significant equity investment in Acies Bio, a Slovenia-based biotechnology firm, to enhance its capabilities in precision microbial fermentation. This partnership aims to advance innovative, sustainable solutions in agriculture and food production. ADM's investment, through its corporate venture arm, ADM Ventures, will help accelerate Acies Bio’s platform technologies, improving their infrastructure and high-throughput capabilities. This collaboration opens new growth opportunities in the microbial technology sector, aligning with ADM's commitment to sustainability.

ADM (NYSE: ADM) has agreed to sell its ethanol production complex in Peoria, Illinois, to BioUrja Group. This divestiture will reduce ADM's ethanol capacity by 135 million gallons, allowing the company to redeploy capital into strategic growth investments. CEO Juan Luciano emphasized that this sale aligns with ADM's ongoing transformation and sustainable growth strategy. The transition will be smooth for the approximately 150 employees at the Peoria facility. BioUrja Group looks forward to enhancing its bio-ethanol production capabilities and contributing to the global energy transition.

On October 19, 2021, Solarea Bio, a biotech firm from Cambridge, MA, announced a technology licensing agreement with ADM (NYSE: ADM). This partnership aims to harness microbial technologies developed by Solarea to address inflammatory conditions like osteoporosis. ADM will explore using these microbes in innovative food and beverage solutions targeting health and wellness. Both companies expressed enthusiasm about the collaboration and its potential to create impactful health solutions. This agreement underscores ADM's commitment to expanding its microbiome strategic platform for growth.